gastric bypass and glp 1 Differences on GLP-1 secretion action between bariatric surgery and Important Role of the GLP-1

They are sub-populations of common diseases, defined narrowly enough to qualify for orphan status

Effective January 1, 2026, Medi-Cal Rx is excluding coverage for GLP-1 medications prescribed for weight loss: [12] Wegovy, Zepbound, Saxenda: Completely removed from the Contract Drugs List for weight loss Ozempic, Mounjaro, Rybelsus: Restricted to Type 2 diabetes onlyweight loss claims will auto-deny Existing prior authorizations end December 31, 2025 Exceptions: Members under age 21 may still qualify via EPSDT Non-weight-loss indications (Zepbound for OSA, Wegovy for cardiovascular) may still get PA approval This does NOT affect Kaiser commercial or employer-sponsored plansonly Medi-Cal members

Over time, repeated purging can cause stomach problems, damage to tooth enamel, and other serious medical complications

This can result in higher blood sugar levels as more insulin is needed to regulate glucose